Trial watch: chemotherapy-induced immunogenic cell death in oncology
Immunogenic cell death (ICD) refers to an immunologically distinct process of regulated cell
death that activates, rather than suppresses, innate and adaptive immune responses. Such …
death that activates, rather than suppresses, innate and adaptive immune responses. Such …
Targeted nanophotoimmunotherapy potentiates cancer treatment by enhancing tumor immunogenicity and improving the immunosuppressive tumor …
K Li, D Yang, D Liu - Bioconjugate Chemistry, 2023 - ACS Publications
Cancer immunotherapy, such as immune checkpoint blockade, chimeric antigen receptor,
and cytokine therapy, has emerged as a robust therapeutic strategy activating the host …
and cytokine therapy, has emerged as a robust therapeutic strategy activating the host …
Light-assisted “nano-neutrophils” with high drug loading for targeted cancer therapy
D Fan, S Wang, R Huang, X Liu, H He… - International Journal of …, 2023 - Taylor & Francis
Background Nanomedicine presents a promising alternative for cancer treatment owing to
its outstanding features. However, the therapeutic outcome is still severely compromised by …
its outstanding features. However, the therapeutic outcome is still severely compromised by …
Immune amplifying hydrogel microspheres with STING activation improve tumor retention for photoimmunotherapy
H Luo, J Chen, T Gao, J Ma, X Zhang, H Hu… - Chemical Engineering …, 2024 - Elsevier
STING agonists have shown a great promise in tumor immunotherapy by activating innate
immunity. However, systemic administration can easily lead to cytokine storm, and poor …
immunity. However, systemic administration can easily lead to cytokine storm, and poor …
An Investigation into the In Vitro Targeted Killing of CD44-Expressing Triple-Negative Breast Cancer Cells Using Recombinant Photoimmunotherapeutics Compared …
N Mungra, FA Nsole Biteghe… - Molecular …, 2024 - ACS Publications
Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer with limited
treatment options. The persistence of highly tumorigenic CD44-expressing subpopulation …
treatment options. The persistence of highly tumorigenic CD44-expressing subpopulation …
Ginsenoside Rg3 combined with near‐infrared photothermal reversal of multidrug resistance in breast cancer MCF‐7/ADR cells
Y Chang, Q Fu, Z Lu, Q Jin, T Jin… - Food Science & …, 2024 - Wiley Online Library
Adriamycin (ADR) is a frequently employed chemotherapeutic agent for the management of
breast cancer. Nevertheless, multidrug resistance (MDR) can impair its therapeutic efficacy …
breast cancer. Nevertheless, multidrug resistance (MDR) can impair its therapeutic efficacy …
Delta-like ligand 3 in small cell lung cancer: potential mechanism and treatment progress
W Yang, W Wang, Z Li, J Wu, X Huang, J Li… - Critical Reviews in …, 2023 - Elsevier
Small cell lung cancer (SCLC) is one of a pathological type of lung cancer, and it is
characterized by invasiveness, high malignancy and refractoriness. The mortality rate of …
characterized by invasiveness, high malignancy and refractoriness. The mortality rate of …
Konzepte zur Aktivierung von photodynamischen Substraten durch tiefes Licht
C Fendinger - 2023 - kups.ub.uni-koeln.de
Photoinduzierte Therapien werden in der Medizin, zB gegen Hautkrankheiten oder-krebs
genutzt und stetig weiterentwickelt. Dabei ist ein limitierender Faktor die Penetrationstiefe …
genutzt und stetig weiterentwickelt. Dabei ist ein limitierender Faktor die Penetrationstiefe …
Plasma Cancer Treatment in Combination With Other Physical Modalities
As a treatment for cancer, cold atmospheric plasma (CAP) is most often used in association
with other modalities. Except in rare cases, patients are presented with a multimodal …
with other modalities. Except in rare cases, patients are presented with a multimodal …